SMTL ID : 7ua5.1

Structure of dephosphorylated human RyR2 in the closed state

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-4-4-mer

Ligands

4 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.4888, C.4891, H.4908, H.4913 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.4888, A:C.4891, A:H.4908, A:H.4913 ZN.4: 4 residues within 4Å: Chain F: C.4888, C.4891, H.4908, H.4913 4 PLIP interactions: 4 interactions with chain F Metal complexes: F:C.4888, F:C.4891, F:H.4908, F:H.4913 ZN.7: 4 residues within 4Å: Chain G: C.4888, C.4891, H.4908, H.4913 4 PLIP interactions: 4 interactions with chain G Metal complexes: G:C.4888, G:C.4891, G:H.4908, G:H.4913 ZN.10: 4 residues within 4Å: Chain H: C.4888, C.4891, H.4908, H.4913 4 PLIP interactions: 4 interactions with chain H Metal complexes: H:C.4888, H:C.4891, H:H.4908, H:H.4913

8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.2: 14 residues within 4Å: Chain A: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915 10 PLIP interactions: 10 interactions with chain A Hydrogen bonds: A:F.4889, A:I.4890, A:H.4913, A:L.4915 Salt bridges: A:K.4166, A:K.4166, A:K.4169, A:K.4169, A:K.4169, A:R.4170 ATP.3: 3 residues within 4Å: Chain A: W.893, W.1007, R.1031 No protein-ligand interaction detected (PLIP) ATP.5: 14 residues within 4Å: Chain F: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915 10 PLIP interactions: 10 interactions with chain F Hydrogen bonds: F:F.4889, F:I.4890, F:H.4913, F:L.4915 Salt bridges: F:K.4166, F:K.4166, F:K.4169, F:K.4169, F:K.4169, F:R.4170 ATP.6: 3 residues within 4Å: Chain F: W.893, W.1007, R.1031 No protein-ligand interaction detected (PLIP) ATP.8: 14 residues within 4Å: Chain G: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915 10 PLIP interactions: 10 interactions with chain G Hydrogen bonds: G:F.4889, G:I.4890, G:H.4913, G:L.4915 Salt bridges: G:K.4166, G:K.4166, G:K.4169, G:K.4169, G:K.4169, G:R.4170 ATP.9: 3 residues within 4Å: Chain G: W.893, W.1007, R.1031 No protein-ligand interaction detected (PLIP) ATP.11: 14 residues within 4Å: Chain H: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915 10 PLIP interactions: 10 interactions with chain H Hydrogen bonds: H:F.4889, H:I.4890, H:H.4913, H:L.4915 Salt bridges: H:K.4166, H:K.4166, H:K.4169, H:K.4169, H:K.4169, H:R.4170 ATP.12: 3 residues within 4Å: Chain H: W.893, W.1007, R.1031 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Miotto, M.C. et al., Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Sci Adv (2022)

Release Date

2022-08-03

Peptides

Ryanodine receptor 2: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1B: BCDE

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

F
B

G
C

H
D

B
E

C
F

D
G

E
H

Ryanodine receptor 2

Peptidyl-prolyl cis-trans isomerase FKBP1B

Related Entries With Identical Sequence